CLINICAL_TRIALS
trial_result
· 2025-12-29
Clinical Trial Update: Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms
Summary
The trial assessing the impact of FCγRIIIA and FCγRIIA receptor polymorphisms on outcomes in Upper Gingival Squamous Cell Carcinoma has completed, with results …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Institut Bergonié | Conditions: Upper Gingival Squamous Cell Carcinoma | Status: COMPLETED | Results posted: 2025-12-29